NCT00180141已完成4 期
Control of Therapy With Elidel vs Placebo in Patients With Atopic Dermatitis Using Bioengineering Methods
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 2
研究概览
简要总结
Atopic dermatitis is a common disease. Emollients and Elidel have both shown to be effective to treat this disease. The research question is, whether the effective component (Elidel) is better than the emollient to improve the skin function.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age > 18 years
- •Atopic dermatitis on both lower arms at least 1% body surface area.
- •Atopic Dermatitis Severity Index (ADSI)-Score >= 6
- •Investigator Global Assessment (IGA)-Score >= 2
排除标准
- •Systemic therapy with immunosuppressive drugs within the past 24 weeks
- •Phototherapy against atopic dermatitis.
- •Antibiotic therapy against atopic dermatitis.
- •Allergy against Elidel.
- •Pregnancy
- •Skin cancer
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
1 期
Emollients in the management of atopic dermatitis in children: prevention of flares.MedDRA version: 14.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858Atopic dermatitisEUCTR2012-004621-24-PLPIERRE FABRE MEDICAMENT347
进行中（未招募）
不适用
Emollients in the management of atopic dermatitis in chidren: prevention of flares.Atopic dermatitisEUCTR2012-004621-24-LTPIERRE FABRE MEDICAMENT409
进行中（未招募）
不适用
Emollients in the management of atopic dermatitis in children: prevention of flares.Atopic dermatitisEUCTR2012-004621-24-EEPIERRE FABRE MEDICAMENT409
进行中（未招募）
1 期
Emollients in the management of atopic dermatitis in children: prevention of flares.Atopic dermatitisEUCTR2012-004621-24-FRPIERRE FABRE MEDICAMENT409
已完成
2 期
A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus HydrocortisoneDermatologic DiseaseNCT05607901Tanta University100